Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Sensitive Tuberculosis”

40 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 40 results

Testing effectiveness (Phase 2)UnknownNCT05926466
What this trial is testing

BTZ-043 Dose Evaluation in Combination and Selection

Who this might be right for
Tuberculosis, PulmonaryOther Specified Pulmonary Tuberculosis
Michael Hoelscher 90
Not applicableActive Not RecruitingNCT05840809
What this trial is testing

Pharmacokinetics of Drugs Used to Treat Drug Sensitive Tuberculosis in Breastfeeding Mother-infant Pairs

Who this might be right for
Tuberculosis ActiveBreastfeedingTuberculosis
University of Liverpool 20
Testing effectiveness (Phase 2)Looking for participantsNCT05807399
What this trial is testing

PanACEA - STEP2C -01

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 390
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Large-scale testing (Phase 3)Study completedNCT03474198
What this trial is testing

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis

Who this might be right for
Tuberculosis, Pulmonary
University College, London 675
Testing effectiveness (Phase 2)Study completedNCT01498419
What this trial is testing

Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 207
Testing effectiveness (Phase 2)Study completedNCT03557281
What this trial is testing

An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 76
Testing effectiveness (Phase 2)Study completedNCT03959566
What this trial is testing

PanACEA Sutezolid Dose-finding and Combination Evaluation

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 75
Testing effectiveness (Phase 2)Looking for participantsNCT07672405
What this trial is testing

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Who this might be right for
Tuberculosis, Pulmonary
Global Alliance for TB Drug Development 100
Testing effectiveness (Phase 2)Study completedNCT01936831
What this trial is testing

High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)

Who this might be right for
Tuberculosis
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 282
Testing effectiveness (Phase 2)Study completedNCT01241188
What this trial is testing

A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB)

Who this might be right for
Tuberculosis
Statens Serum Institut 253
Testing effectiveness (Phase 2)Study completedNCT04044001
What this trial is testing

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Who this might be right for
Pulmonary TuberculosesOther Specified Pulmonary Tuberculosis
Michael Hoelscher 78
Testing effectiveness (Phase 2)Study completedNCT02256696
What this trial is testing

Assessing PA-824 for Tuberculosis (the APT Trial)

Who this might be right for
Pulmonary Tuberculosis
Johns Hopkins University 157
Testing effectiveness (Phase 2)Study completedNCT03563599
What this trial is testing

Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

Who this might be right for
Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB
Qurient Co., Ltd. 60
Not applicableNot Yet RecruitingNCT06921278
What this trial is testing

Development of the Drug and Alcohol Respiratory Health Test

Who this might be right for
Respiratory DiseaseSubstance-Related DisordersCOPD+6 more
King's College London 260
Not applicableLooking for participantsNCT05797649
What this trial is testing

Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)

Who this might be right for
Pleural EffusionHeart FailureMalignant Neoplasm+5 more
Chinese University of Hong Kong 120
Not applicableNot Yet RecruitingNCT07668479
What this trial is testing

Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in Kazakhstan

Who this might be right for
TuberculosisTuberculosis Infection, LatentTuberculosis, Pulmonary, Drug Sensitive
Public Union "Kazakhstan Association of Phthisiopulmonologists" 350
Testing effectiveness (Phase 2)Study completedNCT02279875
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)

Who this might be right for
Pulmonary Tuberculosis
Global Alliance for TB Drug Development 113
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Large-scale testing (Phase 3)Looking for participantsNCT07209761
What this trial is testing

Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 532
Next Page